US$ 20.25
glp-1 discontinuation rates Patients with diabetes who remained on drugs had lower cardiovascular risk New Truveta study highlights patterns
Description
SKU / UPC Barcode: 850049609852
Background/Objectives: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have revolutionized the treatment of type 2 diabetes and obesity

By comparison, it took statins 17 years to reach this level of market penetration, Henry Dimbleby reported in the Financial Times. Furthermore, womens use of these medicines grew more quickly than mens, shown in Gallups data here

Get hungry for local, organic, plant-based & more
